Original Research Article
Year: 2022 | Month: January | Volume: 9 | Issue: 1 | Pages: 1-8
DOI: https://doi.org/10.52403/ijrr.20220101
The Difference of Urinary Neutrophil Gelatinase-Associated Lipocalin Level between Liver Cirrhosis Patients With and Without Hepatorenal Syndrome
Fakhrurrazi Nasution1, Gontar Alamsyah Siregar2, Ilhamd2, Dharma Lindarto3
1Department of Internal Medicine, Faculty of Medicine, Sumatera Utara University, Medan, Indonesia.
2Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Sumatera Utara University, Medan, Indonesia.
3Division of Metabolic and Endocrinology, Department of Internal Medicine, Faculty of Medicine, Sumatera Utara University, Medan, Indonesia.
Corresponding Author: Gontar Alamsyah Siregar
ABSTRACT
Objective: To determine differences of urinary Neutrophil Gelatinase-Associated Lipocalin level in liver cirrhosis patients with or without Hepatorenal Syndrome (HRS).
Methods: This study was conducted on 46 liver cirrhosis patients (20 patients without hepatorenal syndrome, 26 patients with hepatorenal syndrome). Diagnosis of HRS was based on International Ascites Club criteria. Urinary NGAL was examined using ELISA method. Data analysis was performed with p<0,05 stated as statistically significant.
Result: This study showed more HRS cases was found in male than female, with an average age of 53,95 years old for hepatic cirrhosis without HRS, and 57,35 with HRS. The most common cause of this study is Hepatitis B virus, and the highest grade of severity is in Child Pugh-C. The average urinary NGAL level in liver cirrhosis with HRS is 59,39 ± 58,98 ng/ml and 130,78 ± 45,14 ng/ml in liver cirrhosis without HRS.
Conclusion: There was a significant higher urinary NGAL level in liver cirrhosis with HRS (p = 0.000), with the cut-off of urinary NGAL to differentiate cirrhosis patients with and without HRS was 95,115 ng/ml.
Keywords: NGAL, HRS, hepatorenal syndrome, neutrophil gelatinase-associated lipocalin.
[PDF Full Text]